Researchers are actively exploring several strategies to overcome immune resistance in cancer, including:
Combination therapies: Using a combination of immunotherapies and other treatments, such as chemotherapy or radiation, can enhance the overall effectiveness of cancer treatment. Immune checkpoint inhibitors: Drugs like nivolumab and pembrolizumab block immune checkpoints, restoring the ability of immune cells to attack cancer cells. Cancer vaccines: These vaccines aim to stimulate the immune system to recognize and attack cancer cells more effectively. Adoptive cell transfer: This involves the infusion of immune cells that have been engineered or expanded outside the body to target cancer cells. Targeted therapies: Drugs that specifically target cancer cell mechanisms can be used in conjunction with immunotherapies to improve outcomes.
